14.3 C
New York
Tuesday, March 21, 2023

Value Investing Philosophy And Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX)?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Amylyx Pharmaceuticals Inc. (AMLX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.57, or 1.47%, to $39.25. The Amylyx Pharmaceuticals Inc. has recorded 5,140 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

AMLX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $38.68 and fluctuated between $41.92 as its day high and $38.27 as its day low. The current market capitalization of Amylyx Pharmaceuticals Inc. is $2.51B. A total of 0.79 million shares were traded on the day, compared to an average of 789.30K shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AMLX has seen 11 BUY and 0 SELL insider trades, representing the acquisition of 24,031 and the disposition of 0 shares. Over the last 12 months, there were 14 BUYs and 8 SELLs from insiders. Insiders purchased 734,071 shares during that period but sold 1,437,275.

In the most recent transaction, VIKING GLOBAL INVESTORS LP sold 700,000 shares of AMLX for 30.23 per share on Sep 09. After the transaction, the 10% Owner now owns 1,850,940 company shares. In a previous transaction on Sep 08, VIKING GLOBAL INVESTORS LP sold 700,000 shares at 29.37 per share. AMLX shares that 10% Owner owns now total 2,075,470.

Among the insiders who sold shares, ALS Invest 1 B.V. disposed of 60,609 shares on Jul 06 at a per-share price of $20.70. This resulted in the 10% Owner holding 5,895,280 shares of AMLX after the transaction.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AMLX in the last 3 months, the mean price target is $48.80 with high estimates of $51.00 and low estimates of $43.00. In terms of 52-week highs and lows, AMLX has a high of $41.25 and a low of $6.51.

As of this writing, AMLX has an earnings estimate of -$0.97 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.96 per share and a lower estimate of -$0.98. The company reported an EPS of -$0.93 in the last quarter, which was -34.80% lower than expectations of -$0.69.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 6 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMLX is Overweight with a score of 4.67. A total of 5 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles